Obsessive-Compulsive Disorder in the DSM-5

s International: Section B: The Sciences and Engineering,56, 7036.Christenson, G. A., Mackenzie, T. B., Mitchell, J. E., & Callies, A. L. (1991). A placebo controlled, double-blind crossover study of fluoxetine in trichotillomania. AmericanJournal of Psychiatry, 148,1566–1571.Clark, D. M. (1999). Anxiety disorders: Why they persist andhow to treat them. Behaviour Research & Therapy, 37, S5–S27. doi:10.1016/S0005-7967(99)00048-0Clark, D. A. (2004). Cognitive behavioral therapy for OCD.New York, NY: Guilford Press.Cororve, M. B., & Gleaves, D. H. (2001). Body dysmorphicdisorder: A review of conceptualizations, assessment, andtreatment strategies. Clinical Psychology Review, 21, 949–970. doi:10.1016/S0272-7358(00)00075-1Deacon, B. J. (2013). The biomedical model of mentaldisorder: A critical analysis of its validity, utility, andeffects on psychotherapy research. Clinical PsychologyReview, 33, 846–861. doi:10.1016/j.cpr.2012.09.007DeVeaugh-Geiss, J., Moroz, G., Biederman, J. B., Cantwell,D., Fontaine, R., Greist, J. H., . . . Landau, P. (1992). Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder: A multicenter trial. Journal ofthe American Academy of Child and Adolescent Psychiatry, 31,45–49. doi:10.1097/00004583-199201000-00008 Dougherty, D. D., Loh, R., Jenike, M. A., & Keuthen, N. J. (2006). Single modality versus dual modality treatment for trichotillomania: Sertraline, behavioral therapy, or both?Journal of Clinical Psychiatry, 67, 1086–1092. doi:10.4088/ JCP.v67n0711Ferr~ao, Y., Miguel, E., & Stein, D. (2009). Tourette’ssyndrome, trichotillomania, and obsessive–compulsive disorder: How closely are they related? Psychiatry Research,170(1), 32–42. doi:10.1016/j.psychres.2008.06.008 Fineberg, N., Saxena, S., Zohar, J., & Craig, K. (2011). Obsessive-compulsive disorder: Boundary issues. In E. Hollander, J. Zohar, P. J. Sirovatka, & D. A. Regier (Eds.), Obsessive-compulsive spectrum disorders: Refining theresearch agenda for DSM-V (pp. 1–32). Washington, DC:American Psychiatric Association. Foa, E. B., Abramowitz, J. S., Franklin, M. E., & Kozak, M. J. (1999). Feared consequences, fixity of belief, and treatment outcome in patients with obsessive-compulsivedisorder. Behavior Therapy, 30, 717–724. doi:10.1016/S0005-7894(99)80035-5 Foa, E. B., & Kozak, M. J. (1995). DSM-IV field trial: Obsessive-compulsive disorder. American Journal ofPsychiatry, 152, 90–96. Foa, E. B., Liebowitz, M. R., Kozak, M. J., Davies, S.,Campeas, R., Franklin, M. E., . . . Tu, X. (2005).Randomized, placebo-controlled trial of exposure andritual prevention, clomipramine, and their combination in the treatment of obsessive compulsive disorder. American Journal of Psychiatry, 162,151–161. doi:10.1176/appi.ajp.162.1.151 OCD IN DSM-5 ABRAMOWITZ & JACOBY233 Franklin, M. E., Harrison, J. P., & Benavides, K. L. (2012).Obsessive-compulsive and tic-related disorders. Child andAdolescent Psychiatric Clinics of North America, 21, 555–571.doi:10.1016/j.chc.2012.05.008Freeston, M. H., & Ladouceur, R. (1997). What do patientsdo with their obsessive thoughts? Behaviour Research &Therapy, 35, 335–348. doi:10.1016/S0005-7967(96)00094-0Frost, R. O., & Steketee, G. (2008). Compulsive hoarding.In J. S. Abramowitz, D. McKay, & S. Taylor (Eds.),Obsessive-compulsive disorder: Subtypes and spectrum conditions(pp. 76–93). New York, NY: Elsevier.Geller, D. A., Biederman, J., Stewart, S. E., Mullin, B., Martin,A., Spencer, T., & Faraone, S. V. (2003). Which SSRI? Ameta-analysis of pharmacotherapy trials in pediatric obsessive-compulsive disorder. American Journal of Psychiatry,160, 1919–1928. doi:10.1176/appi.ajp.160.11.1919Goodman, W. K., Price, L. H., Rasmussen, S. A., Delgado, P. L., Heninger, G. R., & Charney, D. S. (1989). Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo. Archives ofGeneral Psychiatry, 46, 36–44. doi:10.1001/archpsyc.1989